Tucaresol-based Cancer Treatment System with AI, IoT, and Biomaterial Integration

A novel system combining tucaresol-based pharmaceutical compositions with advanced technologies like AI, IoT, blockchain, and novel biomaterials to create a more effective and personalized cancer treatment approach.

The original patent disclosed tucaresol-based compositions for cancer treatment, but these compositions have limitations in terms of optimal treatment regimens, patient data management, and targeted delivery. The new inventive concept addresses these limitations by integrating the tucaresol-based compositions with AI-powered diagnostic tools, blockchain-based patient data management, IoT-enabled real-time monitoring, and novel biomaterials for sustained release and targeted delivery.

The new system comprises a pharmaceutical composition of Formula (I) and an AI-powered diagnostic tool that identifies optimal treatment regimens based on patient-specific genomic data and real-time monitoring. The system also incorporates blockchain-based patient data management to ensure secure and transparent data storage and sharing. Additionally, the system utilizes IoT-enabled sensors for real-time monitoring and feedback, and novel biomaterials for sustained release and targeted delivery of the tucaresol-based compositions. The integration of these advanced technologies enables a more personalized and effective cancer treatment approach.

The new claims introduce the concept of integrating tucaresol-based compositions with AI, IoT, blockchain, and novel biomaterials, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these distinct technologies to create a more powerful system for cancer treatment.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT-enabled devices, or biomaterials. Variations of the system could also include the integration of additional technologies, such as machine learning or natural language processing, to further enhance the system's capabilities.

The inventive concept has significant commercial potential in the cancer treatment market, particularly in the areas of personalized medicine and targeted therapies. The system's ability to integrate advanced technologies and provide more effective treatment outcomes could lead to increased adoption and market share in the pharmaceutical and biotechnology industries.